MedTrace Logo

Cigarette Pack Inserts for Smoking Cessation

NCT04075682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 387

Last updated 2024-05-13

Study results available
· View outcomes & findings →

Summary

This study will test whether cigarette package inserts (i.e., small printed leaflets inside cigarette packs) with messages about the benefits of cessation and tips for quitting can help smokers quit. To do this, the investigators will conduct a 2 X 2 between-subject experiment in which 380 smokers will be randomized into one of four labeling groups: 1. no inserts or pictorial health warning labels (HWLs); 2. inserts only; 3. pictorial HWLs only; 4. inserts \& pictorial HWLs. Smokers will be given a 14-day supply of their preferred cigarette brand with packs labeled according to their experimental group. Participants will answer a brief survey at the end of each day and four other times each day, using ecological momentary assessment approaches. The investigators will study whether smokers in each group experience different psychological responses and behaviors associated with smoking cessation.

Conditions

  • Smoking Cessation

Interventions

OTHER

Inserts with efficacy messages

Four rotating inserts (i.e., small, printed messages) with messages about cessation benefits (i.e., response efficacy) and tips to quit (i.e., self-efficacy messages) will be placed inside cigarette packs.

OTHER

Pictorial warnings on packs

Four rotating pictorial warnings illustrating the harms of smoking will be printed on labels that will placed on and cover approximately 50% of the cigarette packs.

Sponsors & Collaborators

  • Cornell University

    collaborator OTHER

  • University of Waterloo

    collaborator OTHER

  • University of Tasmania

    collaborator OTHER

  • University of South Carolina

    lead OTHER

Principal Investigators

  • James F Thrasher, PhD · University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-06-29
Completion
2021-06-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04075682 on ClinicalTrials.gov